Elevated TSH in adults treated for hypothyroidism is associated with increased mortality

Context: Numerous studies investigated the link between hypothyroidism and mortality, but a definite conclusion is hard to reach as these were limited by a number of factors, including age of participants, comorbidities and single measurement of thyroid function. Objective: To evaluate the association between TSH and fT4 levels and mortality in patients with levothyroxinetreated hypothyroidism. Design and setting: Observational data of hospitalized patients (2011-2014). TSH and fT4 levels obtained between at least 30 days after discharge and until death or end of follow-up were collected. Median TSH and fT4 levels were stratified into categories. Patients: In total, 611 patients with treated hypothyroidism, aged 60-80 years (72% females, mean age 71 +/- 6 years) were included in the study. Main outcome measure: All-cause mortality up to 66 months after discharge, by TSH and fT4 categories. Results: During follow-up, the average numbers of TSH and fT4 measurements were 5.5 +/- 3.8 and 2.5 +/- 4.2 per patient respectively. Mortality rates were 28%, 29% and 54% with median TSH of 0.5-2.5, 2.5-5.0 and 5.0-10.0 IU/L respectively. Adjusted hazard ratios for mortality with median TSH between 5.0 and 10.0 IU/L were 2.3 (95% CI: 1.6-3.4) and 2.2 (95% CI: 1.6-3.2) compared with patients with TSH between 0.5-2.5 IU/L and 2.5-5 IU/L respectively. There was no difference in mortality between patients with median fT4 10-15 or 15-20 pmol/L. Conclusion: In treated hypothyroid adult patients and serial measurements of thyroid function tests, median TSH levels of 5-10 IU/L are associated with increased mortality with no effect of fT4 levels. Treatment should aim at achieving euthyroidism to improve survival.